ArticleBioprocess and biosystems engineering2026
Metabolic mechanisms underlying osmoprotectant-enhanced xylitol biosynthesis from glucose by Zygoascus hellenicus.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xylitol, a high-value sugar alcohol, holds significant potential for applications in the food and pharmaceutical industries. Biomanufacturing xylitol from low-cost, green feedstocks provides a sustainable alternative to the energy-intensive and highly polluting chemical synthesis process. Current research primarily focuses on xylose-to-xylitol bioconversion, whereas native glucose-to-xylitol converters remain underexplored. In particular, a systematic understanding of their osmotic stress adaptation and metabolic regulation is lacking, which directly impedes the scale-up of xylitol production from low-cost glucose. To address this gap, this study investigated Zygoascus hellenicus, an osmotolerant yeast capable of directly converting glucose to xylitol, and proposed a novel strategy to enhance xylitol production by supplementing exogenous osmoprotectants. Results showed that adding 80 mL/L glycerol or 80 g/L trehalose increased xylitol titers to 28.44 g/L and 23.63 g/L, representing improvements of 41.99% and 17.99%, respectively, compared with the control group. Mechanistic investigations revealed the dual regulatory roles of these osmoprotectants. Physiologically, they enhanced osmotic tolerance, preserved membrane integrity, and stabilized enzyme activity. Metabolically, they significantly activated key enzymes of the pentose phosphate pathway, including glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase (G6PDH and 6PGDH) and inhibited glycolytic enzymes, thereby redirecting carbon flux toward xylitol biosynthesis. Dynamic metabolic flux analysis (dMFA) further confirmed that osmoprotectant treatment substantially increased the metabolic flux through the xylitol synthesis pathway mediated by G6PDH and 6PGDH, while reducing carbon flow in glycolysis. This study provides mechanism-based insights into xylitol production from glucose in a native producer, revealing a green and alternative glucose-based biomanufacturing route.
Indexed as
Identifiers
42287420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.